Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Interviews

Interview: Amethyst’s Stéphane Carré on Fremman Capital deal, European expansion, and radiotherapy investment

HBI spoke with Amethyst CEO Stéphane Carré about the new partnership, expansion plans, the investment climate in radiotherapy, and the role of public-private partnerships in Amethyst’s model.

Exploring Saudi Arabia’s “completely different universe” for healthcare investors, with Youssef Haidar of Nexus Gulf

This interview features in the HBI 2025: Disruptive Innovation: Investing in Healthcare Transformation Conference Report, which was shared with conference delegates, and is available to HBI Deals and Insights and Intelligence members. Saudi Arabia’s rapidly developing private healthcare sector offers significant opportunities for international providers prepared to enter the country with the right partnerships, according […]

How UK cosmetic surgery provider Pall Mall safely navigates demand — an interview with Managing Director Raja K Pitalia

With demand for aesthetics rapidly growing, HBI spoke to Raja K Pitalia, Managing Director of Pall Mall, a private healthcare and cosmetic surgery provider in North West England, about how the company strives to safely meet demand, how the company has evolved, and trends in the sector. 

How AI can reduce face-to-face appointments by 60+% — an interview with Richard Armitage, Ufonia

Ufonia is a UK digital health company that has developed an AI tool that can automate conversations which would normally take place with a clinician. In an interview with HBI, Richard Armitage, Ufonia’s new Commercial Director, explained the huge potential of this technology.

Interview: Exploring NHS market reforms and the UK healthcare investment landscape with Sharon Lamb, Partner at McDermott Will & Emery

With record NHS waiting lists and major structural reforms underway, private healthcare investment in the UK continues to show resilience amidst broader economic uncertainties. Recent government action to transform the NHS are creating new market dynamics, yet investor appetite remains strong, particularly in subsectors serving patients seeking alternatives to lengthy NHS queues. HBI spoke with […]

Why AI will play a central role in drug discovery — in conversation with Boston Consulting Group’s Chris Meier 

Drug discovery is important, but the process is often slow, expensive, and risky.  According to a report by Boston Consulting Group (BCG), an American global management consulting firm, on average, it typically takes 12 to 15 years and about $2.5 billion to bring a single drug to market. Only 9 to 14% of drugs that […]

Spanish and Portuguese hospital groups show us the future of European private healthcare — Alberto Fernandez, Healthcare Activos

Like most healthcare REITs, Healthcare Activos is primarily focused on investing in nursing homes. But since 2018 it has begun investing in hospitals as well. In a conversation with HBI, Co-CEO Alberto Fernandez explained why the largely privately funded hospitals run by Spanish and Portuguese private hospital groups are much more attractive investment prospects than the equivalents in Bismarckian countries.

How can ophthalmology groups across the globe successfully boost growth and value creation? — in conversation with ZEISS

Demand in ophthalmology is growing, driven by an ageing population and a rise in eye-related conditions. This, coupled with exciting new technologies, personalised care solutions, and advances in cataract and refractive surgery, means national and international groups are expanding. HBI spoke with Ana Neves and Michael Achtelik from ZEISS Medical Technology for some initial insights ahead of HBI 2025 on strategies for growth and value creation for ophthalmology groups in different markets across the globe, how international operators can drive commercial and operational excellence, and what technology’s role is in driving performance.

‘Clients are ready to pay if the service is right’ — Daniel Einhorn on the recipe for growth in veterinary care

A veterinary services business is fast becoming a ‘must have’ for every private equity healthcare portfolio. And with that in mind, HBI spoke with Daniel Einhorn, founder and former CEO of French veterinary services provider Sevetys, to better understand why they are such a compelling addition.

“AI should be seen as a tool, not a solution on its own” – in conversation with Martin Møller Paarse, COO, Liva Healthcare

In early February 2025, Liva Healthcare, a UK-based digital health company, acquired Discover Momenta and its subsidiary, Momenta Newcastle, for an undisclosed sum. Liva offers human-led therapeutic intervention programmes aimed at addressing chronic lifestyle diseases, such as type 2 diabetes. HBI caught up with Martin Møller Paarse, COO of Liva Healthcare, to explore the evolving digital healthcare landscape in the UK and Europe, along with investment opportunities, market consolidation, and Liva’s mission in the sector.

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us